Difference between revisions of "LncRNAWiki:Nervous System Diseases"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Disease !width="50"|LncRNAs |- |Alzheimer's disease |''SNHG3'', ''LINC01616'', ''LINC01080'', '...") |
|||
| Line 18: | Line 18: | ||
|facioscapulohumeral muscular dystrophy | |facioscapulohumeral muscular dystrophy | ||
|''DBET'' | |''DBET'' | ||
| + | |- | ||
|Huntington's disease | |Huntington's disease | ||
|''HAR1A'', ''TUG1'', ''MEG3'', ''NOP14-AS1'', ''HTT-AS'', ''BDNF-AS'', ''HAR1B'' | |''HAR1A'', ''TUG1'', ''MEG3'', ''NOP14-AS1'', ''HTT-AS'', ''BDNF-AS'', ''HAR1B'' | ||
Revision as of 14:39, 28 June 2017
| Disease | LncRNAs |
|---|---|
| Alzheimer's disease | SNHG3, LINC01616, LINC01080, BACE1-AS, BCYRN1, HAR1A, SOX2-OT, LINC01772 |
| dermatomyositis | 7SL |
| Down syndrome | DSCR4, DSCR8 |
| Duchenne muscular dystrophy | LINCMD1 |
| facioscapulohumeral muscular dystrophy | DBET |
| Huntington's disease | HAR1A, TUG1, MEG3, NOP14-AS1, HTT-AS, BDNF-AS, HAR1B |
| ischemic stroke | CDKN2B-AS1 |
| multiple sclerosis | IFNG-AS1 |
| myotonic dystrophy | DM1-AS |
| narcolepsy | LINC00165 |
| neural tube defects | H19 |
| neurodevelopmental syndromes | SOX2-OT |
| Parkinson's Disease | MAPT-AS1 |
| Prader-Willi syndrome | MKRN3-AS1, SNHG14, PWRN1, PWRN2, IPW, PWARSN, MKRN3-AS1, H19, MEG8 |
| psychiatric disease | BDNF-AS |
| spinocerebellar ataxia | SCAANT1, ATXN8OS |
| syndromic developmental defect | MIR17HG |
| Usher syndrome type 3 | CLRN1-AS1 |
| West Syndrome | LINC00581 |
